Iris Acquisition Corp, announced that it has issued an unsecured promissory note in the aggregate principal amount up to $1,500,000 on October 4, 2023. The transaction included participation from new lender Liminatus Pharma LLC. The Note matures upon the earlier of: (i) the closing of the Company's business combination, or (ii) thirty days following the termination of the business combination agreement; provided, however, in the event the Company commences liquidation proceedings within such thirty (30) day period, the Note will be cancelled and all amounts due thereunder, including all principal and accrued interest, shall be forgiven.